AstraZeneca
AZN
AZN
752 hedge funds and large institutions have $20.4B invested in AstraZeneca in 2021 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 264 increasing their positions, 268 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 783 → 752 (-31)
22% less funds holding in top 10
Funds holding in top 10: 18 → 14 (-4)
23% less first-time investments, than exits
New positions opened: 77 | Existing positions closed: 100
Holders
752
Holding in Top 10
14
Calls
$548M
Puts
$409M
Top Buyers
| 1 | +$1.96B | |
| 2 | +$205M | |
| 3 | +$153M | |
| 4 |
Citigroup
New York
|
+$116M |
| 5 |
BlackRock
New York
|
+$86.9M |
Top Sellers
| 1 | -$661M | |
| 2 | -$348M | |
| 3 | -$307M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$229M |
| 5 |
D.E. Shaw & Co
New York
|
-$214M |